Rubicon Research
₹1,508.6+31.50 (+2.13%)as of 2026-10-16
- Market Cap
- ₹25,002Cr.
- P/E Ratio
- 86.8
- P/B Ratio
- 19.32
- EPS (TTM)
- ₹17.38
- Day Range
- ₹1,468 – ₹1,544.9
- Div Yield
- 0.1%
- ROCE
- 28.4%
- ROE
- 27%
52W Low: ₹57152W High: ₹1,899
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 65.0% a year over three years.
- Debt is 0.24× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Rubicon_Research — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 86.8P/E: 86.8 | P/B: 19.32Growth
GrowingSales CAGR — 3Y: 65% · 1Y: 47%Profitability
High MarginROCE: 28.4% | ROE: 27%Key Metrics
Valuation
PEG Ratio 0.56
Price / Sales 12.91x
Book Value ₹78.1
Margins & returns
Operating Margin 23%
Net Margin 14.9%
Return on Assets 12.4%